I am bullish on healthcare stocks, especially pharmaceuticals, due to conservative valuations. Check out the healthcare ...
Fintel reports that on December 15, 2025, B of A Securities maintained coverage of Eli Lilly and (NYSE:LLY) with a Buy ...
Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...
Here’s a closer look at the top pharmaceutical companies that have earned favorable rankings from Wolfe Research analysts. Johnson & Johnson takes the top spot with growth primarily driven by new ...
Discover why Eli Lilly's stock downturn may present new opportunities. Learn about valuation, Zepbound pricing, and 2026 ...
Eli Lilly (LLY) reached $1 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.
Investing.com -- Moody’s Ratings has affirmed Eli Lilly and Company ’s Aa3 senior unsecured notes ratings and long-term issuer rating while revising the outlook to positive from stable, the rating ...
Novo Nordisk stock plunges 42% so far in 2025 as GLP-1 competition, price cuts, guidance trims and restructuring plans cloud ...
Eli Lilly 's (NYSE: LLY) share price has soared over the past five years (up 530%). In fact, it's hard to find a single ...
Major stock indexes ended mixed Thursday, with the Dow Jones Industrial Average and S&P 500 closing at record highs but the ...
Eli Lilly surged into a rarefied tier of corporate giants on November 21, becoming the first pharmaceutical company in history to reach a US$1 trillion market valuation This milestone has been driven ...
Dow Jones Top Company Headlines at 9 AM ET: Altria CEO Gifford to Retire in 2026, CFO Mancuso Tapped to Take Over | Lilly ... Altria CEO Gifford to Retire in 2026, CFO Mancuso Tapped to Take Over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results